Steven Pearson, ICER president (Jeff Rumans)
ICER calls out three drugs from BMS and Lilly in report on unsupported price increases in California
Drug pricing watchdog ICER on Thursday released its final report on drug price increases in California that were unsupported by new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
